This study has 2 main limitations: 1) we did not include KTx recipients who did not receive RTx induction therapy, so it remains unclear whether FCGR3A polymorphisms influence neutropenia risk during CMV infection without RTx. Here, FCGR3A is linked to cytomegalovirus infection.